Trial intelligence / Profile preview

Intranasal esketamine plus dexmedetomidine vs dexmedetomidine for pediatric imaging sedation

ChiCTR2400088919Phase 4Not yet recruiting

Sponsor
Maternal and Child Health Hospital of Hubei Province
Start
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in Procedural anxiety and None comparing Dexmedetomidine intranasal with Dexmedetomidine + esketamine intranasal (2 arms). Primary endpoints: heart rate, oxygen saturation and 1 more. Planned start Aug 2024; status: not yet recruiting.

02

Drugs

dexmedetomidineesketamine
03

Conditions

Procedural anxiety

Beyond the preview

Go deeper on ChiCTR2400088919.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400088919.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call